JNJ-38893777
CAS No. 951135-00-5
JNJ-38893777 ( JNJ38893777 )
Catalog No. M16802 CAS No. 951135-00-5
JNJ-38893777 is a potent and selective transient receptor potential vanilloid 1 (TRPV1) channel antagonist for treatment of ociceptive and neuropathic pain.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 873 | Get Quote |
|
50MG | 1782 | Get Quote |
|
100MG | 2250 | Get Quote |
|
200MG | Get Quote | Get Quote |
|
500MG | Get Quote | Get Quote |
|
1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameJNJ-38893777
-
NoteResearch use only, not for human use.
-
Brief DescriptionJNJ-38893777 is a potent and selective transient receptor potential vanilloid 1 (TRPV1) channel antagonist for treatment of ociceptive and neuropathic pain.
-
DescriptionJNJ-38893777 is a potent and selective transient receptor potential vanilloid 1 (TRPV1) channel antagonist for treatment of ociceptive and neuropathic pain.Pain Phase 1 Clinical
-
SynonymsJNJ38893777
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorTRP/TRPV Channel
-
Research AreaNeurological Disease
-
IndicationPain
Chemical Information
-
CAS Number951135-00-5
-
Formula Weight536.53
-
Molecular FormulaC26H26F6N6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name2-(1-piperidinyl)-N-[4-(trifluoromethyl)phenyl]-7-[3-(trifluoromethyl)-2-pyridinyl]-6,7,8,9-tetrahydro-5H-pyrimido[4,5-d]azepin-4-amine
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Manitpisitkul P, et al. Clin Drug Investig. 2015 Jun;35(6):353-63.
2. Meents JE, et al. J Headache Pain. 2015;16:57.
2. Meents JE, et al. J Headache Pain. 2015;16:57.
molnova catalog
related products
-
N-Ethyl-p-menthane-3...
N-Ethyl-p-menthane-3-carboxamide is an agonist of TRPM8( EC50 : 3.7 μM).
-
TETRAHYDROPIPERINE
TETRAHYDROPIPERINE is a natural product derived from piperine can be used to treat convulsion epilepsy relieve pain and control insects.
-
CIM0216
CIM0216 is a synthetic TRPM3 activator whose potency and apparent affinity greatly exceeds that of the canonical TRPM3 agonist.